Nebraska legislation · 109th Legislature
Nebraska LB195: Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications
Status: Signed into law, April 8, 2025
What the bill says
From the amended text:
AM240 AM240 LB195 LB195 AJC - 02/10/2025 AJC - 02/10/2025 AMENDMENTS TO LB195 (Amendments to Standing Committee amendments, AM135) Introduced by Bosn, 25. 1. Strike the original sections and all amendments thereto and insert the following new sections: Section 1. Section 28-470, Revised Statutes Cumulative Supplement, 2024, is amended to read: 28-470 (1) A health professional who is authorized to prescribe or dispense an opioid overdose reversal medication naloxone, if acting with reasonable care, may prescribe, administer, or dispense such medication naloxone to any of the following persons without being subject to administrative action or criminal prosecution: (a) A person who is apparently experiencing or who is likely to experience an opioid-related overdose; or (b) A family member, friend, or other person in a position to assist a person who is apparently experiencing or who is likely to experience an opioid-related overdose. (2) A family member, friend, or any other person, including school personnel, who is in a position to assist a person who is apparently experiencing or who is likely to experience an opioid-related overdose, other than an emergency responder or peace officer, is not subject to actions under the Uniform Credentialing Act, administrative action, or criminal prosecution if the person, acting in good faith: (a) Obtains an opioid overdose reversal medication , obtains naloxone from a health professional, …
Sponsors
- Glen Meyer (NP, 17) · primary sponsor
Latest actions
- : Approved by Governor on April 7, 2025
- : Presented to Governor on April 3, 2025
- : President/Speaker signed
- : Passed on Final Reading 47-0-2
- : Placed on Final Reading
- : Advanced to Enrollment and Review for Engrossment
- : Placed on Select File
- : Advanced to Enrollment and Review Initial
- : Judiciary AM135 adopted
- : Bosn AM240 adopted
Votes
- Final Reading (April 3, 2025): 47 yea, 0 nay, passed
- General File: AM 135 Judiciary AM 240 Bosn (February 26, 2025): 42 yea, 0 nay, passed
- General File: AM 135 Judiciary (February 26, 2025): 43 yea, 0 nay, passed
- General File: ADVANCE TO E&R INITIAL (February 26, 2025): 44 yea, 0 nay, passed
Common questions
- What is LB195?
- LB195 is a bill in the Nebraska Legislature (109th Legislature): Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications.
- What is the status of LB195?
- Signed into law as of April 8, 2025. Latest action: Approved by Governor on April 7, 2025 (April 8, 2025).
- Who sponsored LB195?
- Glen Meyer (NP, 17).
- Where is the official record for LB195?
- On the Nebraska Legislature website: https://nebraskalegislature.gov/bills/view_bill.php?DocumentID=59308
Source: official Nebraska record. Tracked by Delilah, AI for legislation across all 50 states and Congress.